Business
– Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced that all proposals were approved at its Annual General Meeting of Shareholders held earlier today. These proposals included...
Hi, what are you looking for?
– Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced that all proposals were approved at its Annual General Meeting of Shareholders held earlier today. These proposals included...
– Atox Bio will conduct a Phase II study for a soft tissue infections treatment. Atox Bio, which develops therapeutics for severe infections, has...
– Glass Lewis even recommends against board motions to which Benny Landa has not objected. A day after ISS recommended investors to support Teva...
See also: Teva Pharmaceuticals Denies Picking New Chairman – I am an industrialist, not a financial investor. I focus on running my own...
– Several months ago, Accellta granted a similar license to Japanese nutrition and health giant, Ajinomoto. – – Stem cell company Accellta this month...
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced that the Company has filed a citizen petition (CP) regarding the approvability of purported generic versions of...
– Silicon Valley and Startup Nation are combining their resources. The State of Israel and the State of California entered into a...
– Mesupron, which targets gastrointestinal and other cancers, has been licensed from Wilex. RedHill Biopharma Ltd. (Nasdaq: RDHL); TASE: RDHL) has expanded its late clinical-stage gastrointestinal-focused pipeline...
RedHill Biopharma Ltd.(NASDAQ: RDHL; TASE: RDHL) , today announced preliminary positive data from a pre-clinical study with RHB-104 for the treatment of type 1...
– The Trendlines Group announced it has completed the acquisition of intellectual property developed within the framework of an R&D agreement with Ireland...